Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Obstetric Risk Assessment & Cesarean-delivery in Labor Estimation Using Artificial Intelligence

NCT: NCT07430358 · RECRUITING

NCT IDNCT07430358
StatusRECRUITING
Start Date2026-05-19
Completion2027-04-30

Brief Summary

ORACLE-AI is a single-center, open-label, randomized clinical trial comparing primiparous women managed with a real-time machine-learning dashboard against a concurrent control group receiving standard intrapartum care. Participants are randomized 1:1 at the onset of labor. The intervention group has the AI dashboard visible in their electronic health record, while the control group does not. The primary hypothesis is that the use of continuous AI-based risk estimates will be non-inferior to standard care in terms of unplanned cesarean\–delivery rates (uCD), with potential secondary benefits in maternal and neonatal outcomes.

Frequently Asked Questions

What is Obstetric Risk Assessment & Cesarean-delivery in Labor Estimation Using Artificial Intelligence?

Obstetric Risk Assessment & Cesarean-delivery in Labor Estimation Using Artificial Intelligence is a clinical trial registered under NCT07430358. Current status: RECRUITING.

What is the status of NCT07430358?

The current status of NCT07430358 (Obstetric Risk Assessment & Cesarean-delivery in Labor Estimation Using Artificial Intelligence) is: RECRUITING.

When did Obstetric Risk Assessment & Cesarean-delivery in Labor Estimation Using Artificial Intelligence start?

Obstetric Risk Assessment & Cesarean-delivery in Labor Estimation Using Artificial Intelligence started on 2026-05-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.